查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853709

血栓除去裝置市場（按器械類型、手術類型、最終用戶和分銷管道分類）—2025-2032年全球預測

Neurothrombectomy Devices Market by Device Type, Procedure Type, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血栓除去裝置市場規模將達到 23.4182 億美元，複合年成長率為 13.09%。

關鍵市場統計數據
基準年2024年 8.75億美元
預計年份：2025年 9.9209億美元
預測年份 2032 23.4182億美元
複合年成長率 (%) 13.09%

建立臨床、營運和採購基礎，以影響現代急性中風護理環境中神經血栓切除裝置的選擇。

神經血栓切除裝置已成為急性中風治療路徑中的關鍵環節，這主要得益於臨床的快速應用、手術技術的創新以及醫療環境的不斷演變。本文概述了影響裝置設計、採購決策和應用曲線的關鍵技術、臨床促進因素以及相關人員事項。透過將各種裝置置於目前的手術方案中，本文闡明了技術屬性如何轉化為實際的臨床應用效用和操作偏好。

臨床醫生和醫療系統領導者如今面臨這樣的局面：器械的選擇與影像處理能力、再灌注時間以及醫療機構的容量息息相關。因此，製造商優先考慮的是易用性、與現有導管室工作流程的兼容性以及在不同血管解剖結構中一致的臨床性能。同時，支付方和採購團隊更重視總醫療成本和後續療效，進而推動臨床證據與採購策略的更緊密結合。

在此背景下，引言部分提供了一個視角，用於審視技術變革、關稅影響、細分市場動態、區域格局以及公司層面的策略。本文旨在幫助相關人員結合自身的營運和臨床優先事項來解讀這些洞察，並將其轉化為產品開發、市場推廣和供應鏈最佳化的可行計劃。

梳理正在重塑急性中風治療設備設計、應用偏好和策略重點的技術、臨床和系統層面的融合力量。

神經血栓切除術領域正經歷一場變革，技術、​​臨床和系統層面的多重因素共同推動急性缺血性腦中風的治療方式重塑。影像技術的進步和從入院到再灌注流程的簡化，使得器械的輸送性和可追蹤性變得愈發重要，促使設計不斷迭代，優先考慮更細的入路、更精準的導航和更強的抽吸能力。同時，臨床證據也不斷完善抽吸優先和聯合治療兩種策略的選擇標準，鼓勵器材製造商投資研發多功能、整合的解決方案。

專科中風中心的擴張、多學科中風團隊的日益重視以及適宜的門診手術中心的興起，正在影響著醫療器械的配置和服務內容。監管路徑和上市後監測提高了績效聲明的嚴格性，製造商也透過建立更明確的臨床註冊和真實世界證據計畫來應對這項挑戰。同時，從手術規劃軟體到人工智慧影像分診等數位化技術的應用，為醫療器材融入更廣泛的醫療生態系統而非僅僅作為獨立產品提供了契機。

總而言之，這些轉變將加速創新週期，提高臨床檢驗的標準，並對現有企業和新參與企業施加策略壓力，促使它們在療效、易用性和整體流程效率方面展現差異化價值。因此，成功的公司將能夠使其產品開發與不斷發展的醫療保健路徑和相關人員的期望保持一致。

分析累積關稅環境和2025年貿易政策調整如何重塑相關人員的供應鏈韌性、籌資策略和定價動態。

近期貿易政策的發展以及2025年生效的關稅調整，為神經血栓切除術器械的全球供應鏈引入了新的變數。這些變化帶來的累積影響遠不止於直接的成本上漲，還會波及製造地的選擇、關鍵零件的籌資策略以及跨境分銷的經濟效益。為此，許多製造商正在重新評估其供應商關係，探索近岸外包、雙重採購以及增加庫存緩衝等策略，以緩解關稅帶來的波動。這些變更將對採購時間表以及與醫院和經銷商的合約條款產生後續影響。

醫院和專科中心面臨更複雜的採購計算，不僅要考慮設備定價，還要考慮服務連續性和前置作業時間風險。特別是那些依賴單一供應商和即時庫存模式的機構，不得不重新談判條款或採取緊急庫存策略。面對利潤淨利率的萎縮，經銷商正在透過提供配套服務、寄售模式以及區域化的消毒和物流解決方案來重新定義其價值提案，以應對不斷上漲的關稅相關成本並保持競爭力。

監管和報銷條件與關稅效應相互作用，共同影響醫療器械的普及時間。不斷上漲的採購成本使得支付方更加關注成本效益和長期療效，從而加強了對醫療器械優越性聲明的審查力度。因此，製造商必須提供可靠的臨床和經濟證據，以證明其定價在採購談判中的合理性。總而言之，2025年的關稅環境正在推動製造、分銷和採購等各相關人員進行策略調整，凸顯了供應鏈韌性和實證定價策略的重要性。

深入剖析決定神經血栓切除解決方案臨床適用性、採購偏好和商業性定位的設備、手術、最終用戶和分銷管道細分方面的細微差別。

細分市場層面的動態變化揭示了因器械類型、手術方法、最終用戶環境和通路而異的細微機會和限制。在器械類型細分市場中，抽吸導管可根據內徑進一步區分。中等直徑導管優先考慮靈活性和在迂曲解剖結構中的導航性，而大直徑設計則優先考慮抽吸能力，以便快速清除血栓。組合系統涵蓋了從將抽吸和取出功能整合到單一工作流程中的完全整合系統，到能夠將一流組件組合起來以應對複雜病例的獨立輔助解決方案。血栓摘取支架呈現塗層和非塗層設計的獨特細分，其中表面處理會影響血栓與器械的相互作用和輸送特性。

按手術類型進行分類反映了不同的臨床工作流程和預期器械性能。抽吸血栓切除術通常用於可透過抽吸快速實現管腔再通的病例，而當需要徑向力和基於支架的介入時，則首選使用取栓器的機械血栓切除術。兩種方法可以按順序進行，先嘗試抽吸，然後根據需要部署取栓器；或者可以協調地同時使用互補器械，以最大限度地提高首次通過率並最大限度地縮短手術時間。

門診手術中心需要精簡高效的系統，並儘可能減少輔助設備；而設有綜合卒中中心和初級卒中中心的醫院則需要能夠與各種導管室配置兼容，並能應對各種複雜病例的設備。專科神經病學中心則期望獲得可靠的臨床證據和訓練支持，以最佳化治療效果。直銷模式強調廠商與臨床醫生之間的合作關係，電子商務支援標準耗材的快速補充，而第三方分銷商（包括獨立分銷商和增值分銷商）則在提供物流和臨床培訓服務的同時，拓展了業務覆蓋範圍。

檢驗了美洲、歐洲、中東和非洲以及亞太地區醫療設備相關人員在臨床、監管和商業性存在的區域差異所帶來的影響。

區域格局正在影響美洲、歐洲、中東和非洲以及亞太地區的臨床實踐、監管預期和商業策略，給市場參與企業帶來了不同的挑戰。在美洲，對成熟的中風網路和綜合中風中心的投資推動了先進取栓設備的快速普及，而更廣泛的地域差異則持續催生了對能夠促進遠端分流和傳輸通訊協定的解決方案的需求。因此，供應商通常會優先考慮全面的服務模式、完善的培訓計劃以及與不同醫療保健系統相關的實證實踐。

歐洲、中東和非洲各地監管協調、報銷差異以及卒中治療基礎設施的不同，既帶來了機遇，也帶來了挑戰。跨國監管路徑鼓勵採用模組化產品策略和區域性臨床實務。以結果為導向的支付模式獎勵商提供區域性真實世界證據。同時，亞太地區的醫療保健系統高度重視成本控制和價值驗證，影響了採購週期和競標結構。

亞太地區醫療保健成熟度有差異，主要市場大力投資中風治療，而新興市場則優先考慮可擴展、經濟高效的解決方案。基礎設施的快速擴張和專家能力的提升，推動了對兼具臨床療效和可靠供應的醫療器材的需求。在整個亞太地區，策略性參與企業正根據當地的健保報銷機制、培訓要求和物流實際情況調整其商業性策略，以最大限度地提高市場相關性和普及率。

從全球領導企業到專業創新者和契約製造，評估不同的企業策略如何影響產品藍圖和競爭優勢。

公司層面的動態反映了一系列策略姿態，涵蓋了從大型全球醫療技術公司到敏捷的專業研發和契約製造。成熟的跨國公司通常利用廣泛的臨床試驗項目、廣泛的分銷網路和一體化的服務來維持其市場地位，而挑戰者則專注於細分市場差異化，例如提高藥物輸送效率、獨特的恢復機製或針對特定解剖結構或血栓成分挑戰的聯合治療。為了應對競爭壓力，合作和有針對性的協作正變得越來越普遍，以此來加快產品上市速度並擴大臨床檢驗範圍。

製造商們也正在重新分配研發投資，致力於開發能夠縮短手術時間和提高首次療效的功能。同時，規模較小的創新企業則優先考慮能夠快速進入特定地域市場的監管策略，並規劃在初步臨床應用後擴大規模。製造外包和策略採購合作夥伴在擴大產能和降低關稅風險方面發揮著至關重要的作用，這促使許多公司製定正式的供應鏈風險管理通訊協定。

此外，透過培訓、流程支援和數據主導的市場研究實現服務差異化正成為一項關鍵的競爭優勢。能夠有效結合產品創新、便利的臨床教育和長期療效追蹤的公司，將更有利於影響醫院的處方箋，並長期贏得臨床醫生的青睞。

一項切實可行的多方相關人員策略，旨在協調產品創新、供應鏈韌性和循證採購，以實現持續的臨床應用和競爭優勢。

產業領導者應採取多維策略，將產品創新與供應鏈韌性和相關人員為中心的商業模式結合。製造商應優先發展模組化設備組合，使臨床醫生能夠根據手術複雜程度選擇合適的設備，同時保持生產規模經濟效益。此外，供應商多元化以及探索區域組裝或製造中心可以降低關稅主導的衝擊，並提高對區域採購週期的應對力。

臨床醫師和醫院採購團隊應加強以臨床醫師主導的評估框架，強調實際績效指標、訓練支援和整體流程效率，而非僅僅關注單位成本。這種方法有助於做出更明智的採購決策，並更好地與以結果為導向的報銷模式相契合。經銷商和通路合作夥伴必須透過提供物流最佳化、寄售模式和完善的臨床培訓服務來提升自身提案，從而支援不同醫療機構的設備應用和維護。

最後，政策制定者和支付者應考慮建立獎勵機制，鼓勵循證醫學證據的產生，支持公平獲取先進的卒中治療方案，並促進公私合作以加強醫療服務網路。透過實施涵蓋研發、分銷和臨床應用的協調策略，相關人員可以在維持商業性可行性的同時，加速顯著改善病患預後。

採用多層次的研究途徑，整合臨床專家訪談、監管和程序文獻以及供應鏈分析，確保獲得有效且可操作的見解。

本調查方法採用多層次方法，整合定性和定量數據，旨在平衡臨床相關性和實際操作性。主要研究包括對介入性神經放射科醫生、神經外科醫生、中風計畫主任、醫院採購負責人和分銷主管進行結構化訪談，以了解手術偏好、採購標準和供應鏈限制。次要研究涵蓋同行評審的臨床研究、監管文件、器械標籤和公開的手術指南，以支持臨床療效聲明和實踐模式。

分析人員交叉參考了設備註冊資訊、會議記錄和製造商技術文檔，以識別設備迭代、手術結果和培訓實踐中的常見趨勢。供應鏈分析包括供應商映射、組件採購審查和物流評估，以發現關稅敏感性和前置作業時間漏洞。在適當情況下，透過後續專家諮詢檢驗研究結果，以確保結論反映當前的臨床實踐和營運實際情況。

市場調查固有的限制已被認知並加以緩解。獨家定價安排和保密採購合約限制了對具體商業條款的了解，而快速發展的臨床證據可能會改變臨床實踐模式。為了克服這些局限性，我們提出了一些建議，強調調查方法和資料來源的透明度，在資料不完整時採取保守的推斷，並優先考慮適應性和持續的證據收集。

對結論的全面回顧強調了神經血栓切除術的長期成功將取決於臨床表現、營運韌性和實證商業化。

我們的結論概括了技術創新、流程改善和近期貿易動態如何共同影響神經血栓切除術生態系統的策略決策。在重視快速再灌注和簡化工作流程的醫療領域，那些在首次通過率、操作便利性和跨平台相容性方面具有顯著優勢的器材將保持競爭力。同時，關稅帶來的供應鏈壓力凸顯了製造彈性、採購多元化和增值分銷模式在維持服務連續性方面的重要性。

儘管區域性因素和最終用戶需求需要量身定製商業策略，但可靠的臨床證據和上市後績效追蹤在採購考量中仍然至關重要。注重產品差異化、並提供全面的臨床醫生培訓和結果透明化的公司最有可能贏得持續的市場認可。同時，將採購決策與長期結果指標掛鉤的醫院和醫療系統，即使面臨短期成本壓力，也能更好地證明其對先進醫療設備投資的合理性。

最後，隨著神經血栓切除術領域的不斷成熟，相關人員積極將臨床、營運和商業性方面整合到連貫策略中的利益相關者，將更有可能改善患者的治療效果並獲得永續的競爭優勢。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 採用最佳化徑向力的先進血栓摘取支架設計，可提高缺血性中風介入治療中血栓捕獲效率。
  • 一種小型遠端通路導管，能夠引導醫師穿過複雜迂曲的腦血管系統，進行標靶血栓切除術。
  • 它整合了即時人工智慧影像分析，以指導設備選擇和手術流程。
  • 為了縮短手術時間並提高首次手術成功率，結合抽吸和支架取出的技術已經出現。
  • 採用機器人輔助神經血管介入平台可提高手術精度並減少外科醫生受到的輻射暴露。
  • 開發一種可生物吸收的血栓除去裝置，以最大程度地減少血管損傷和長期異物併發症。
  • 不斷變化的報銷政策和基於價值的醫療模式對醫院採用血栓切除技術的影響
  • 中風發病率上升和血管內治療基礎設施不斷擴大，推動了亞太市場的投資。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8.血栓除去裝置市場（依器械類型分類）

  • 吸痰導管
    • 中口徑
    • 大直徑
  • 複雜系統
    • 整合系統
    • 獨立輔助
  • 支架取栓器
    • 塗層
    • 未塗層

9. 依手術類型血栓除去裝置市場

  • 抽吸血栓切除手術
  • 綜合方法
    • 一連串
    • 同時
  • 機械血栓切除術

第10章 依最終用戶分類的血栓除去裝置市場

  • 門診手術中心
  • 醫院
    • 綜合卒中中心
    • 初級卒中中心
  • 專科神經學中心

第11章血栓除去裝置市場（依通路分類）

  • 直銷
  • 電子商務
  • 第三方經銷商
    • 獨立銷售代理
    • 增值分銷商

第12章血栓除去裝置市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章血栓除去裝置市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國血栓除去裝置市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Stryker Corporation
    • Medtronic plc
    • Penumbra, Inc.
    • Johnson & Johnson
    • Boston Scientific Corporation
    • Terumo Corporation
    • Imperative Care, Inc.
    • Rapid Medical Ltd.
    • Acandis GmbH & Co. KG
    • Phenox GmbH
Product Code: MRR-8C74ADFC1598

The Neurothrombectomy Devices Market is projected to grow by USD 2,341.82 million at a CAGR of 13.09% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 875.00 million
Estimated Year [2025] USD 992.09 million
Forecast Year [2032] USD 2,341.82 million
CAGR (%) 13.09%

Establishing the clinical, operational, and procurement foundations that shape neurothrombectomy device choices across contemporary acute stroke care settings

Neurothrombectomy devices have become a pivotal focal point across acute stroke care pathways, driven by rapid clinical adoption, procedural innovations, and evolving care settings. This introduction frames the essential technologies, clinical drivers, and stakeholder priorities that shape device design, procurement decisions, and adoption curves. By situating device types within contemporary procedural choices, the narrative clarifies how technical characteristics translate into real-world clinical utility and operational preferences.

Clinicians and health system leaders now confront a landscape where device selection intersects with imaging capabilities, time-to-reperfusion imperatives, and institutional capabilities. As a result, manufacturers are prioritizing ease of use, compatibility with existing cath lab workflows, and consistent clinical performance across variable vascular anatomies. Concurrently, payers and procurement teams emphasize total cost of care and downstream outcomes, prompting a closer alignment between clinical evidence and purchasing strategies.

In this context, the introduction establishes the lens through which subsequent sections examine technological shifts, tariff influences, segmentation-specific dynamics, regional patterns, and company-level strategies. It prepares stakeholders to interpret insights through operational and clinical priorities, and to translate them into actionable plans for product development, market access, and supply chain resilience.

Mapping the converging technological, clinical and system-level forces that are reshaping device design, adoption preferences, and strategic priorities in acute stroke care

The neurothrombectomy landscape is undergoing transformative shifts driven by converging technological, clinical and system-level forces that are redefining how acute ischemic stroke is treated. Imaging advances and faster door-to-reperfusion workflows have elevated the importance of device deliverability and trackability, prompting design iterations that prioritize lower-profile access, improved navigation, and enhanced aspiration performance. At the same time, clinical evidence continues to refine selection criteria for aspiration-first versus combined approaches, encouraging device makers to invest in versatility and integrated solutions.

Operational trends are also reshaping adoption: the expansion of specialized stroke centers, greater emphasis on multidisciplinary stroke teams, and the growth of ambulatory surgical centers where appropriate are influencing device configuration and service offerings. Regulatory pathways and post-market surveillance are adding rigor to performance claims, and manufacturers are responding with clearer clinical registries and real-world evidence programs. Meanwhile, digital augmentation-ranging from procedural planning software to AI-enabled imaging triage-creates opportunities for devices to be positioned as part of broader therapeutic ecosystems rather than stand-alone products.

Collectively, these shifts are accelerating innovation cycles, raising the bar for clinical validation, and creating strategic pressure on incumbents and new entrants to demonstrate differentiated value across efficacy, ease of use, and total procedural efficiency. As a result, successful players are those that align product development with evolving care pathways and stakeholder expectations.

Analyzing how the cumulative tariff environment and trade policy adjustments in 2025 are reshaping supply chain resilience, procurement strategies, and pricing dynamics across stakeholders

Recent trade policy developments and tariff adjustments implemented in 2025 have introduced new variables into global supply chains for neurothrombectomy devices. The cumulative effects extend beyond immediate cost uplifts, influencing manufacturing footprint decisions, sourcing strategies for critical components, and the economics of cross-border distribution. In response, many manufacturers are reassessing supplier relationships and exploring nearshoring, dual sourcing, and increased inventory buffers to mitigate tariff-driven volatility. These shifts have downstream implications for procurement timelines and contractual terms with hospitals and distributors.

Hospitals and specialized centers confront a more complex procurement calculus where device pricing must be considered alongside service continuity and lead-time risks. In particular, institutions that rely on single-source distributors or just-in-time inventory models have had to renegotiate terms or adopt contingency stock strategies. Distributors facing margin compression are redefining their value proposition by offering bundled services, consignment models, or localized sterilization and logistics solutions to preserve competitiveness while absorbing incremental tariff-related costs.

Regulatory and reimbursement landscapes interact with tariff effects to shape adoption timing. Payers emphasize cost-effectiveness and long-term outcomes, thereby increasing scrutiny on claims of device superiority when acquisition costs rise. Consequently, manufacturers must present robust clinical and economic evidence to justify pricing during procurement negotiations. In sum, the tariff environment of 2025 has catalyzed strategic repositioning across manufacturing, distribution, and purchasing stakeholders, reinforcing the need for supply chain resilience and evidence-based pricing strategies.

Unpacking device, procedural, end-user and distribution segmentation nuances that determine clinical fit, procurement preferences, and commercial positioning across neurothrombectomy solutions

Segment-level dynamics reveal nuanced opportunities and constraints that vary by device type, procedural approach, end-user setting and distribution pathway. Within device type segmentation, aspiration catheters are further differentiated by bore size, with intermediate bore variants emphasizing flexibility and navigation in tortuous anatomy while large bore designs prioritize aspiration capacity for rapid clot removal. Combined systems occupy a spectrum from fully integrated platforms that pair aspiration and retrieval functions in a single workflow to standalone adjunct solutions that allow clinicians to combine best-in-class components during complex cases. Stent retrievers present their own segmentation between coated and uncoated designs, where surface treatments can influence clot-device interactions and deliverability profiles.

Procedure type segmentation reflects distinct clinical workflows and device performance expectations. Aspiration thrombectomy is often selected for cases where fast lumen recanalization via suction is feasible, whereas mechanical thrombectomy with retrievers is preferred when radial force and scaffold-based engagement are required. The combined approach can be executed sequentially-attempting aspiration first and then deploying a retriever if needed-or simultaneously, with complementary devices used in concert to maximize first-pass effect and minimize procedural time.

End-user segmentation also matters: ambulatory surgical centers demand streamlined, efficient systems with minimal ancillary equipment, whereas hospitals, including both comprehensive and primary stroke centers, require devices that integrate with diverse cath lab setups and support variable case complexity. Specialized neurology centers expect robust clinical evidence and training support to optimize outcomes. Distribution channel segmentation influences how products reach the point of care; direct sales models emphasize manufacturer-clinician relationships, e-commerce supports rapid replenishment for standard disposables, and third-party distributors-both independent and value-added-extend geographic reach while providing logistical and clinical training services.

Examining how regional differences across the Americas, Europe Middle East & Africa, and Asia-Pacific create distinct clinical, regulatory and commercial imperatives for device stakeholders

Regional patterns shape clinical practice, regulatory expectations, and commercial strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific, yielding distinct imperatives for market participants. In the Americas, established stroke networks and investment in comprehensive stroke centers have fostered rapid adoption of advanced thrombectomy devices, while broader geographic disparities continue to create demand for solutions that facilitate remote triage and transfer protocols. Consequently, suppliers often prioritize comprehensive service models, robust training programs, and evidence generation relevant to diverse health systems.

In Europe, Middle East & Africa, regulatory harmonization, reimbursement variation, and differing stroke care infrastructures create both opportunities and complexities. Multi-country regulatory pathways encourage modular product strategies and region-specific clinical engagement. Payment models that reward outcome-based care have incentivized manufacturers to generate localized real-world evidence. In parallel, healthcare systems across the region emphasize cost containment and value demonstration, which affects procurement timelines and tender structures.

Asia-Pacific exhibits heterogeneity in healthcare maturity, with leading markets investing heavily in stroke capabilities and emerging markets emphasizing scalable, cost-effective solutions. Rapid infrastructure expansion and growing specialist capacity are increasing demand for devices that combine clinical efficacy with supply reliability. Across all regions, strategic entrants tailor commercial approaches to local reimbursement mechanisms, training requirements, and logistical realities to maximize market relevance and adoption.

Evaluating how diverse company strategies, from global incumbents to specialized innovators and contract manufacturers, are shaping product roadmaps and competitive differentiation

Company-level dynamics reflect a spectrum of strategic postures ranging from large global medtech firms to nimble specialized developers and contract manufacturers. Established multinational players often leverage broad clinical trial programs, extensive distribution networks, and integrated service offerings to maintain position, while challengers focus on niche differentiation through improved deliverability, unique retrieval mechanisms, or combination therapies that target specific anatomical or clot composition challenges. In response to competitive pressure, alliances and targeted collaborations have grown more common as a way to accelerate time-to-market and expand clinical validation efforts.

Manufacturers are also reallocating R&D investment toward features that reduce procedure time and improve first-pass effect, since these outcomes resonate with clinicians and payers alike. At the same time, smaller innovators increasingly prioritize regulatory strategies that enable rapid entry in select regional markets with the intent to scale after initial clinical adoption. Contract manufacturing and strategic sourcing partners play a critical role in enabling capacity expansion and mitigating tariff exposure, prompting many companies to formalize supply chain risk management protocols.

Furthermore, service differentiation through training, procedural support, and data-driven post-market surveillance has emerged as a key competitive lever. Companies that effectively combine product innovation with accessible clinical education and longitudinal outcome tracking are better positioned to influence hospital formularies and gain clinician preference over time.

Practical, multi-stakeholder strategies to align product innovation, supply chain resilience and evidence-driven procurement for sustained clinical adoption and competitive advantage

Industry leaders should adopt a multi-dimensional strategy that aligns product innovation with supply chain robustness and stakeholder-centric commercial models. Manufacturers need to prioritize modular device portfolios that allow clinicians to tailor device selection to procedural complexity while maintaining economies of scale in production. Concurrently, diversifying supplier bases and exploring regional assembly or manufacturing hubs will reduce exposure to tariff-driven disruptions and improve responsiveness to local procurement cycles.

Clinicians and hospital procurement teams should strengthen clinician-led evaluation frameworks that emphasize real-world performance metrics, training support, and total procedural efficiency rather than focusing solely on unit price. This approach will facilitate informed purchasing decisions and enable better alignment with outcome-oriented reimbursement models. Distributors and channel partners must enhance their value proposition by offering logistics optimization, consignment models, and robust clinical training services that support device adoption and retention within varied care settings.

Finally, policymakers and payers should consider mechanisms that incentivize evidence generation, support equitable access to advanced stroke interventions, and encourage public-private collaboration to strengthen care networks. By implementing coordinated strategies across development, distribution, and clinical adoption, stakeholders can accelerate meaningful improvements in patient outcomes while sustaining commercial viability.

A layered research approach integrating clinical expert interviews, regulatory and procedural literature, and supply chain analysis to ensure validated and actionable insights

This research synthesizes qualitative and quantitative inputs using a layered methodology designed to balance clinical validity with operational realism. Primary research included structured interviews with interventional neuroradiologists, neurosurgeons, stroke program directors, hospital procurement officers, and distribution executives to capture procedural preferences, purchasing criteria, and supply chain constraints. Secondary research encompassed peer-reviewed clinical studies, regulatory filings, device labeling, and publicly available procedural guidelines to corroborate clinical performance claims and practice patterns.

Analysts triangulated insights with device registries, conference proceedings, and manufacturer technical documentation to identify recurring trends in device iteration, procedural outcomes, and training practices. Supply chain analysis incorporated vendor mapping, component sourcing reviews, and logistics assessments to highlight tariff sensitivities and lead-time vulnerabilities. Where appropriate, findings were validated through follow-up expert consultations to ensure conclusions reflect current clinical practice and operational realities.

Limitations inherent to market research were acknowledged and mitigated: proprietary pricing arrangements and confidential procurement contracts constrain visibility into certain commercial terms, and rapidly evolving clinical evidence can shift practice patterns. To address these limitations, the methodology emphasizes transparent sourcing, conservative inference where data are incomplete, and recommendations that prioritize adaptability and ongoing evidence collection.

Concluding synthesis highlighting how clinical performance, operational resilience, and evidence-based commercialization determine long-term success in neurothrombectomy

The conclusion distills how technological innovation, procedural evolution, and recent trade dynamics collectively influence strategic decision-making across the neurothrombectomy ecosystem. Devices that deliver demonstrable improvements in first-pass effect, ease of navigation, and cross-platform compatibility will retain a competitive edge as care pathways emphasize rapid reperfusion and streamlined workflows. At the same time, tariff-induced supply chain pressures have underscored the importance of manufacturing agility, diversified sourcing, and value-added distribution models in maintaining service continuity.

Region-specific considerations and end-user priorities demand tailored commercial strategies, while robust clinical evidence and post-market performance tracking remain decisive in procurement deliberations. Companies that combine focused product differentiation with comprehensive clinician training and outcome transparency are most likely to win sustained adoption. Meanwhile, hospitals and health systems that align purchasing decisions with long-term outcome metrics can better justify investments in advanced devices despite short-term cost pressures.

In closing, stakeholders that proactively integrate clinical, operational, and commercial dimensions into cohesive strategies will be best positioned to deliver improved patient outcomes and realize durable competitive advantage as the neurothrombectomy field continues to mature.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Advanced stent retriever designs with optimized radial force for improved clot capture efficiency in ischemic stroke interventions
  • 5.2. Miniaturized distal access catheters enabling navigation in challenging tortuous cerebral vasculature for targeted thrombectomy
  • 5.3. Integration of real time artificial intelligence driven imaging analytics to guide device selection and procedural workflow
  • 5.4. Emergence of combined aspiration plus stent retrieval techniques to reduce procedure times and enhance first pass efficacy
  • 5.5. Adoption of robotics assisted neuroendovascular platforms to improve procedural precision and reduce operator radiation exposure
  • 5.6. Development of bioresorbable neurothrombectomy devices to minimize vessel trauma and long term foreign body complications
  • 5.7. Impact of evolving reimbursement policies and value based care models on hospital adoption of thrombectomy technologies
  • 5.8. Growing investment in Asia Pacific markets driven by rising stroke incidence and expansion of endovascular care infrastructure

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurothrombectomy Devices Market, by Device Type

  • 8.1. Aspiration Catheters
    • 8.1.1. Intermediate Bore
    • 8.1.2. Large Bore
  • 8.2. Combined Systems
    • 8.2.1. Integrated System
    • 8.2.2. Standalone Adjunct
  • 8.3. Stent Retrievers
    • 8.3.1. Coated
    • 8.3.2. Uncoated

9. Neurothrombectomy Devices Market, by Procedure Type

  • 9.1. Aspiration Thrombectomy
  • 9.2. Combined Approach
    • 9.2.1. Sequential
    • 9.2.2. Simultaneous
  • 9.3. Mechanical Thrombectomy

10. Neurothrombectomy Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
    • 10.2.1. Comprehensive Stroke Centers
    • 10.2.2. Primary Stroke Centers
  • 10.3. Specialized Neurology Centers

11. Neurothrombectomy Devices Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. E Commerce
  • 11.3. Third Party Distributor
    • 11.3.1. Independent Distributor
    • 11.3.2. Value Added Distributor

12. Neurothrombectomy Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Neurothrombectomy Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Neurothrombectomy Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Stryker Corporation
    • 15.3.2. Medtronic plc
    • 15.3.3. Penumbra, Inc.
    • 15.3.4. Johnson & Johnson
    • 15.3.5. Boston Scientific Corporation
    • 15.3.6. Terumo Corporation
    • 15.3.7. Imperative Care, Inc.
    • 15.3.8. Rapid Medical Ltd.
    • 15.3.9. Acandis GmbH & Co. KG
    • 15.3.10. Phenox GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NEUROTHROMBECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. NEUROTHROMBECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NEUROTHROMBECTOMY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTERMEDIATE BORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTERMEDIATE BORE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTERMEDIATE BORE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTERMEDIATE BORE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTERMEDIATE BORE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTERMEDIATE BORE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY LARGE BORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY LARGE BORE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY LARGE BORE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY LARGE BORE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY LARGE BORE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY LARGE BORE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STANDALONE ADJUNCT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STANDALONE ADJUNCT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STANDALONE ADJUNCT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STANDALONE ADJUNCT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STANDALONE ADJUNCT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STANDALONE ADJUNCT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY UNCOATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY UNCOATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY UNCOATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY UNCOATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY UNCOATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY UNCOATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION THROMBECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION THROMBECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION THROMBECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION THROMBECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION THROMBECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION THROMBECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SEQUENTIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SEQUENTIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SEQUENTIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SEQUENTIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SEQUENTIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SEQUENTIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SIMULTANEOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SIMULTANEOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SIMULTANEOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SIMULTANEOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SIMULTANEOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SIMULTANEOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMPREHENSIVE STROKE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMPREHENSIVE STROKE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMPREHENSIVE STROKE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMPREHENSIVE STROKE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMPREHENSIVE STROKE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMPREHENSIVE STROKE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRIMARY STROKE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRIMARY STROKE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRIMARY STROKE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRIMARY STROKE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRIMARY STROKE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRIMARY STROKE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SPECIALIZED NEUROLOGY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SPECIALIZED NEUROLOGY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SPECIALIZED NEUROLOGY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SPECIALIZED NEUROLOGY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SPECIALIZED NEUROLOGY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SPECIALIZED NEUROLOGY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY E COMMERCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY E COMMERCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY E COMMERCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INDEPENDENT DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INDEPENDENT DISTRIBUTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INDEPENDENT DISTRIBUTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INDEPENDENT DISTRIBUTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INDEPENDENT DISTRIBUTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INDEPENDENT DISTRIBUTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VALUE ADDED DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VALUE ADDED DISTRIBUTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VALUE ADDED DISTRIBUTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VALUE ADDED DISTRIBUTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VALUE ADDED DISTRIBUTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VALUE ADDED DISTRIBUTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2024 (USD MILLION)
  • TABLE 290. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2025-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MI